Active Ingredient: FRUQUINTINIB
Proprietary Name: FRUZAQLA
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 5MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N217564
Product Number: 002
Approval Date: Nov 8, 2023
Applicant Holder Full Name: TAKEDA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information
